ולוויר

País: Israel

Língua: hebraico

Origem: Ministry of Health

Ingredientes ativos:

VALACICLOVIR AS HYDROCHLORIDE 500 MG

Disponível em:

RAFA LABORATORIES LTD

Código ATC:

J05AB11

Forma farmacêutica:

FILM COATED TABLETS

Via de administração:

PER OS

Fabricado por:

PHARMATHEN S.A., GREECE

Grupo terapêutico:

VALACICLOVIR

Indicações terapêuticas:

Valovir is indicated for the treatment of herpes zoster (shingles) in immunocopotent adults. Valovir accelerates the resolution of pain, it reduces the duration, and the proportion of patients with zoster-associated pain, which includes acute and post-herpetic neuralgia. The efficacy of valaciclovir in immunocompromised patients has not been established.Valovir is indicated for the treatment of the initial and recurrent genital herpes due to herpes simplex infection. Valovir is indicated for the prevention (suppression) of recurrent herpes simplex infections (herpes genitalis). Prophylaxis of cytomegalovirus infection and disease, following organ transplantation. For the treatment of cold sores (herpes labialis).

Data de autorização:

2013-05-01